Multicentre study of medication reconciliation in paediatric onco-hematology.

Autor:	Cuervas-Mons Vendrell M; Servicio de Farmacia, Hospital Infantil Universitario Niño Jesús, Madrid, España. Electronic address: margarita.cuervasmons@salud.madrid.org., Iturgoyen Fuentes DP; Servicio de Farmacia, Hospital Infantil Universitario Niño Jesús, Madrid, España., Villaronga Flaque M; Servicio de Farmacia, Hospital Sant Joan de Déu, Barcelona, España., Cabañas Poy MJ; Servicio de Farmacia, Hospital Universitario Vall´Hebron, Barcelona, España., Fernández-Llamazares CM; Servicio de Farmacia, Hospital General Universitario Gregorio Marañón, Madrid, España., Álvarez Del Vayo C; Servicio de Farmacia, Hospital Universitario Virgen del Rocío, Sevilla, España., Gallego Fernández C; Servicio de Farmacia, Hospital Regional Universitario Carlos Haya, Málaga, España., Martínez Roca C; Servicio de Farmacia, Complejo Hospitalario La Coruña, La Coruña, España., Hernández Gago Y; Servicio de Farmacia, Complejo Hospitalario Universitario Insular, Gran Canaria, España., García Robles A; Servicio de Farmacia, Hospital Universitario y Politécnico La Fe, Valencia, España., Garrido Corro B; Servicio de Farmacia, Hospital Virgen de la Arrixaca, Murcia, España.
Jazyk:	English; Spanish; Castilian
Zdroj:	Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2023 Nov-Dec; Vol. 47 (6), pp. 261-267. Date of Electronic Publication: 2023 Jul 07.
DOI:	10.1016/j.farma.2023.06.004
Abstrakt:	Objective: To determine the prevalence of reconciliation errors (RE) on admission to hospital in the paediatric onco-haematological population in order to check whether they are similarly susceptible to these RE as adults and to describe the characteristics of the patients who suffer them. Methods: A 12-month prospective, multicentre study of medication reconciliation on admission in the paediatric onco-haematological population to assess the incidence of RE and describe the characteristics of the patients in whom they occur. Results: Medication reconciliation was performed in 157 patients. At least 1 medication discrepancy was detected in 96 patients. Of the discrepancies detected, 52.1% were justified by the patient's new clinical situation or by the physician, while 48.9% were determined to be RE. The most frequent type of RE was the "omission of a medication", followed by "a different dose, frequency or route of administration". A total of 77 pharmaceutical interventions were carried out, 94.2% of which were accepted. In the group of patients with a number equal to or greater than 4 drugs in home treatment, there was a 2.1-fold increase in the probability of suffering a RE. Conclusions: In order to avoid or reduce errors in one of the critical safety points such as transitions of care, there are measures such as medication reconciliation. In the case of complex chronic paediatric patients, such as onco-haematological patients, the number of drugs as part of home treatment is the variable that has been associated with the presence of medication RE on admission to hospital, with the omission of some medication being the main cause of these errors. (Copyright © 2023 Sociedad Española de Farmacia Hospitalaria (S.E.F.H). Publicado por Elsevier España, S.L.U. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu